Exka Inc. – LP Spotlight
Quebec-based Extraction and Research Lab to Focus on Cannabis Derivatives – LPC
Exka Inc. is not the first cannabis extraction specialist in Quebec. But Founder and CEO Maxime Paris said they are the first alternative.
“We are not the only ones in the world, but in Quebec, there is only another one with an extraction licence, Hexo, and another company which is trying to obtain one,” he said. (Please note: all quotes and information are translated from the original French-language Le Journal article. See link to original article below.)
Exka’s 25,000-square-foot, $12-million processing plant was built on an old golf course in Mirabel, a north-west suburb of Montreal. Its focus is on extraction, but the facility also houses a plant tissue culture lab. It plans to create its own products, but also work with licensed producers with their extraction needs. Other related services offered include cloning, micropropogation, and genetic material storage.
The company received its Health Canada Processing and Cultivation licences on February 28, 2020.
Exka to Focus on Derived Cannabis Products – LPC
Initially, Exka will serve the pharmaceutical market. But Paris said he’s open to the recreational market, too.
“We want to supply the pharmaceutical industry – that’s our niche – but the markets will develop towards derived products over the next few years,” he said.
Those derived products include cannabis edibles, topicals, and oils. The article also suggests that Exka would be open to co-creating a cannabis beverage.
Exka expects that demand for extracts will rise by 50% every year. “The advantage of cannabis derivatives is that you can really control what you take.”
According to Le Journal, the cannabis pharmaceutical industry is worth $2 billion, while the recreational industry is $8 billion. About half of the recreational market will be “non-smokable products” including edibles.
Exka is privately owned by “Quebec entrepreneurs” Paris said.
This editorial content from the LPC News Team provides analysis, insight, and perspective on current news articles. To read the source article this commentary is based upon, please click on the link below.
